0001209191-19-021555.txt : 20190328
0001209191-19-021555.hdr.sgml : 20190328
20190328094005
ACCESSION NUMBER: 0001209191-19-021555
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190328
FILED AS OF DATE: 20190328
DATE AS OF CHANGE: 20190328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burton Karen L
CENTRAL INDEX KEY: 0001697095
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37614
FILM NUMBER: 19710206
MAIL ADDRESS:
STREET 1: 5960 HEISLEY ROAD
CITY: MENTOR
STATE: OH
ZIP: 44060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS plc
CENTRAL INDEX KEY: 0001624899
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 981203539
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: RUTHERFORD HOUSE
STREET 2: STEPHENSONS WAY
CITY: DERBY
STATE: X0
ZIP: DE21 6LY
BUSINESS PHONE: (440) 354-2600
MAIL ADDRESS:
STREET 1: RUTHERFORD HOUSE
STREET 2: STEPHENSONS WAY
CITY: DERBY
STATE: X0
ZIP: DE21 6LY
FORMER COMPANY:
FORMER CONFORMED NAME: Steris plc
DATE OF NAME CHANGE: 20151102
FORMER COMPANY:
FORMER CONFORMED NAME: New STERIS Ltd
DATE OF NAME CHANGE: 20141125
FORMER COMPANY:
FORMER CONFORMED NAME: Solar New HoldCo Ltd
DATE OF NAME CHANGE: 20141112
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-28
1
0001624899
STERIS plc
STE
0001697095
Burton Karen L
C/O RUTHERFORD HOUSE, STEPHENSONS WAY
CHADDESDEN
DERBY
X0
DE21 6LY
UNITED KINGDOM
0
1
0
0
VP, Controller & CAO
Ordinary Shares, 10 pence par value
2019-03-28
4
D
0
8404
D
0
D
Employee Stock Option (right to buy)
36.09
2019-03-28
4
D
0
3800
D
2021-05-31
Ordinary Shares
3800
0
D
Employee Stock Option (right to buy)
29.94
2019-03-28
4
D
0
3700
D
2022-05-30
Ordinary Shares
3700
0
D
Employee Stock Option (right to buy)
45.34
2019-03-28
4
D
0
4040
D
2023-05-31
Ordinary Shares
4040
0
D
Employee Stock Option (right to buy)
53.52
2019-03-28
4
D
0
3400
D
2024-05-30
Ordinary Shares
3400
0
D
Employee Stock Option (right to buy)
66.15
2019-03-28
4
D
0
2852
D
2025-05-28
Ordinary Shares
2852
0
D
Employee Stock Option (right to buy)
69.72
2019-03-28
4
D
0
2600
D
2026-06-01
Ordinary Shares
2600
0
D
Employee Stock Option (right to buy)
77.07
2019-03-28
4
D
0
4000
D
2027-05-30
Ordinary Shares
4000
0
D
Employee Stock Option (right to buy)
114.22
2019-03-28
4
D
0
7900
D
2028-05-31
Ordinary Shares
7900
0
D
7,016 of these ordinary shares are restricted and vest as follows: 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; and 1,332 on May 31, 2022.
Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,800 ordinary shares of STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,700 ordinary shares of STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,040 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,400 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,852 ordinary shares of STERIS for $66.15 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 650 on June 1, 2017, 650 on June 1, 2018, 650 on June 3, 2019 and 650 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,600 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 1,975 on May 31, 2019; 1,975 on June 1, 2020; 1,975 on June 1, 2021 and 1,975 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,900 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2019-03-28